ovarian cancer
Conditions
Interventions
experimental group:Qi-Invigorating Blood-Activating and Detoxifying Formula Combined with Conventional Western Medicine
Sponsors
China Academy of Chinese Medical Sciences Guanganmen Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: a. Ovarian cancer patients aged 18-70 years who have achieved maximum clinical remission (complete or partial remission) after completing scheduled surgery or chemotherapy. b. Clinically staged as III or IV with pathological diagnosis of primary epithelial high-grade serous ovarian cancer. c. Chemotherapy completion time = 6 months. d. TCM syndrome differentiation as qi deficiency and blood stasis syndrome. e. ECOG score of 0 to 2. f. Expected survival = 3 months. g. Agree to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: a. Combined with other malignant tumors. b. Combined with severe diseases of heart liver kidney hematopoietic system etc. c. Pregnant women and lactating women. d. Patients with mental or neurological dysfunction who are unable to cooperate. e. Patients known to be allergic to the study drugs. f. Patients currently participating in other investigational drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1-year cumulative progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| syndrome in traditional Chinese medicine;the Functional Assessment of Cancer Therapy Ovary cancer-specific; | — |
Countries
China
Contacts
Public ContactWenping Lu
China Academy of Chinese Medical Sciences Guang'anmen Hospital
Outcome results
None listed